tiprankstipranks
Advertisement
Advertisement

HK:9606 Stock Latest News

Duality Biotherapeutics Gains Shareholder Backing for Governance and Capital Mandates
Company AnnouncementsDuality Biotherapeutics Gains Shareholder Backing for Governance and Capital Mandates
9d ago
9606
Duality Biotherapeutics Grants RSUs to Key Staff Under 2025 Share Scheme
PremiumCompany Announcements
Duality Biotherapeutics Grants RSUs to Key Staff Under 2025 Share Scheme
9d ago
9606
Duality Biotherapeutics Revamps Company Secretarial and Governance Structure in Hong Kong
PremiumCompany Announcements
Duality Biotherapeutics Revamps Company Secretarial and Governance Structure in Hong Kong
9d ago
9606
Duality Biotherapeutics Wins SSE Acceptance for Planned RMB Share Issue
PremiumCompany Announcements
Duality Biotherapeutics Wins SSE Acceptance for Planned RMB Share Issue
23d ago
9606
Duality Biotherapeutics Advances Plan for RMB Share Listing on Shanghai Sci-Tech Board
PremiumCompany Announcements
Duality Biotherapeutics Advances Plan for RMB Share Listing on Shanghai Sci-Tech Board
26d ago
9606
Duality Biotherapeutics Sets 2026 AGM With Capital Mandates on Agenda
PremiumCompany AnnouncementsDuality Biotherapeutics Sets 2026 AGM With Capital Mandates on Agenda
1M ago
9606
Duality Biotherapeutics Launches US$40 Million Buyback as Chairman Plans Stake Increase
Premium
Company Announcements
Duality Biotherapeutics Launches US$40 Million Buyback as Chairman Plans Stake Increase
2M ago
9606
Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC
Premium
Company Announcements
Duality Biotherapeutics Exercises U.S. Cost and Profit-Sharing Option for BioNTech ADC
2M ago
9606
Duality Biotherapeutics Wins Shareholder Approval for RMB Share Issue and Sci-Tech Board Listing
PremiumCompany Announcements
Duality Biotherapeutics Wins Shareholder Approval for RMB Share Issue and Sci-Tech Board Listing
2M ago
9606
Duality Biotherapeutics Calls EGM to Approve RMB Share Issue and Sci-Tech Board Listing Framework
PremiumCompany Announcements
Duality Biotherapeutics Calls EGM to Approve RMB Share Issue and Sci-Tech Board Listing Framework
3M ago
9606
Duality Biotherapeutics Plans RMB Share Issue and Sci-Tech Board Listing
PremiumCompany Announcements
Duality Biotherapeutics Plans RMB Share Issue and Sci-Tech Board Listing
3M ago
9606
Duality Biotherapeutics Wins China BLA Acceptance for Key HER2 Breast Cancer Drug
PremiumCompany Announcements
Duality Biotherapeutics Wins China BLA Acceptance for Key HER2 Breast Cancer Drug
3M ago
9606
Duality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates
PremiumCompany AnnouncementsDuality Biotherapeutics Sets April 29, 2026 Extraordinary General Meeting and Book Closure Dates
3M ago
9606
Duality Biotherapeutics: Strong ADC Portfolio and Upcoming Catalysts Support Upside and Maintain Buy Rating
Premium
Ratings
Duality Biotherapeutics: Strong ADC Portfolio and Upcoming Catalysts Support Upside and Maintain Buy Rating
3M ago
Duality Biotherapeutics Narrows Adjusted Loss as Lead ADCs Hit Key Clinical Milestones
Premium
Company Announcements
Duality Biotherapeutics Narrows Adjusted Loss as Lead ADCs Hit Key Clinical Milestones
3M ago
9606
Duality Biotherapeutics Reshapes Board and Finance Leadership to Back R&D Strategy
PremiumCompany Announcements
Duality Biotherapeutics Reshapes Board and Finance Leadership to Back R&D Strategy
3M ago
9606
Duality Biotherapeutics Details Board and Committee Structure
PremiumCompany Announcements
Duality Biotherapeutics Details Board and Committee Structure
3M ago
9606
Duality Biotherapeutics Sets March Board Meeting on 2025 Results and Dividend
PremiumCompany Announcements
Duality Biotherapeutics Sets March Board Meeting on 2025 Results and Dividend
4M ago
9606
Duality Biotherapeutics Reports Encouraging Prostate Cancer Data for Lead ADC at ASCO GU 2026
PremiumCompany Announcements
Duality Biotherapeutics Reports Encouraging Prostate Cancer Data for Lead ADC at ASCO GU 2026
4M ago
9606
Duality Biotherapeutics Shareholders Approve 2025 Equity Incentive Scheme and Mandate Limits
PremiumCompany AnnouncementsDuality Biotherapeutics Shareholders Approve 2025 Equity Incentive Scheme and Mandate Limits
6M ago
9606
Duality Biotherapeutics Proposes 2025 Share Scheme to Boost Growth
Premium
Company Announcements
Duality Biotherapeutics Proposes 2025 Share Scheme to Boost Growth
7M ago
9606
Duality Biotherapeutics Announces EGM for 2025 Share Scheme Approval
Premium
Company Announcements
Duality Biotherapeutics Announces EGM for 2025 Share Scheme Approval
7M ago
9606

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >